These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27742667)

  • 1. Pathogenic variants in KCTD7 perturb neuronal K+ fluxes and glutamine transport.
    Moen MN; Fjær R; Hamdani EH; Laerdahl JK; Menchini RJ; Vigeland MD; Sheng Y; Undlien DE; Hassel B; Salih MA; El Khashab HY; Selmer KK; Chaudhry FA
    Brain; 2016 Dec; 139(Pt 12):3109-3120. PubMed ID: 27742667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutation in potassium channel related gene KCTD7 and progressive myoclonic epilepsy.
    Krabichler B; Rostasy K; Baumann M; Karall D; Scholl-Bürgi S; Schwarzer C; Gautsch K; Spreiz A; Kotzot D; Zschocke J; Fauth C; Haberlandt E
    Ann Hum Genet; 2012 Jul; 76(4):326-31. PubMed ID: 22606975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygous
    Burke EA; Sturgeon M; Zastrow DB; Fernandez L; Prybol C; Marwaha S; Frothingham EP; Ward PA; Eng CM; Fresard L; Montgomery SB; Enns GM; Fisher PG; Wolfe LA; Harding B; Carrington B; Bishop K; Sood R; Huang Y; Elkahloun A; Toro C; Bassuk AG; Wheeler MT; Markello TC; Gahl WA; Malicdan MCV
    J Neurogenet; 2021; 35(2):74-83. PubMed ID: 33970744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing identifies compound heterozygous KCTD7 mutations in a girl with progressivemyoclonus epilepsy.
    Mei L; Huang Y; Chen J; He X; Lin S; Liao L; Wang X; Huang X; Sha Y; Ji Z; Li P
    Clin Chim Acta; 2019 Jun; 493():87-91. PubMed ID: 30825425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.
    Kousi M; Anttila V; Schulz A; Calafato S; Jakkula E; Riesch E; Myllykangas L; Kalimo H; Topçu M; Gökben S; Alehan F; Lemke JR; Alber M; Palotie A; Kopra O; Lehesjoki AE
    J Med Genet; 2012 Jun; 49(6):391-9. PubMed ID: 22693283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage analysis and exome sequencing identify a novel mutation in KCTD7 in patients with progressive myoclonus epilepsy with ataxia.
    Farhan SM; Murphy LM; Robinson JF; Wang J; Siu VM; Rupar CA; Prasad AN; ; Hegele RA
    Epilepsia; 2014 Sep; 55(9):e106-11. PubMed ID: 25060828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature.
    Yoganathan S; Whitney R; Thomas M; Danda S; Chettali AM; Prasad AN; Farhan SMK; AlSowat D; Abukhaled M; Aldhalaan H; Gowda VK; Kinhal UV; Bylappa AY; Konanki R; Lingappa L; Parchuri BM; Appendino JP; Scantlebury MH; Cunningham J; Hadjinicolaou A; El Achkar CM; Kamate M; Menon RN; Jose M; Riordan G; Kannan L; Jain V; Manokaran RK; Chau V; Donner EJ; Costain G; Minassian BA; Jain P
    Epilepsia; 2024 Mar; 65(3):709-724. PubMed ID: 38231304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive myoclonic epilepsy-associated gene KCTD7 is a regulator of potassium conductance in neurons.
    Azizieh R; Orduz D; Van Bogaert P; Bouschet T; Rodriguez W; Schiffmann SN; Pirson I; Abramowicz MJ
    Mol Neurobiol; 2011 Aug; 44(1):111-21. PubMed ID: 21710140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of a potassium channel-related gene in progressive myoclonic epilepsy.
    Van Bogaert P; Azizieh R; Désir J; Aeby A; De Meirleir L; Laes JF; Christiaens F; Abramowicz MJ
    Ann Neurol; 2007 Jun; 61(6):579-86. PubMed ID: 17455289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCTD7-related progressive myoclonic epilepsy: report of three Indian families and review of literature.
    Narayanan DL; Somashekar PH; Majethia P; Shukla A
    Clin Dysmorphol; 2022 Jan; 31(1):6-10. PubMed ID: 34866617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCTD7-related progressive myoclonus epilepsy.
    Van Bogaert P
    Epileptic Disord; 2016 Sep; 18(S2):115-119. PubMed ID: 27629772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenic gene variants and clinical phenotype features of 26 children with progressive myoclonic epilepsy].
    Zhang J; Zhang YH; Chen JY; Ji TY; Yang ZX; Yang XL; Sun W; Zhang LP; Wu XR
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):458-464. PubMed ID: 31216804
    [No Abstract]   [Full Text] [Related]  

  • 13. A very rare form of autosomal dominant progressive myoclonus epilepsy caused by a novel variant in the PRICKLE1 gene.
    Algahtani H; Al-Hakami F; Al-Shehri M; Shirah B; Al-Qahtani MH; Abdulkareem AA; Naseer MI
    Seizure; 2019 Jul; 69():133-139. PubMed ID: 31035234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kctd7 deficiency induces myoclonic seizures associated with Purkinje cell death and microvascular defects.
    Liang JH; Alevy J; Akhanov V; Seo R; Massey CA; Jiang D; Zhou J; Sillitoe RV; Noebels JL; Samuel MA
    Dis Model Mech; 2022 Sep; 15(9):. PubMed ID: 35972048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.
    Staropoli JF; Karaa A; Lim ET; Kirby A; Elbalalesy N; Romansky SG; Leydiker KB; Coppel SH; Barone R; Xin W; MacDonald ME; Abdenur JE; Daly MJ; Sims KB; Cotman SL
    Am J Hum Genet; 2012 Jul; 91(1):202-8. PubMed ID: 22748208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
    Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
    Nascimento FA; Andrade DM
    Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive myoclonic epilepsy-associated gene Kctd7 regulates retinal neurovascular patterning and function.
    Alevy J; Burger CA; Albrecht NE; Jiang D; Samuel MA
    Neurochem Int; 2019 Oct; 129():104486. PubMed ID: 31175897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive myoclonus epilepsy and ceroidolipofuscinosis 14: The multifaceted phenotypic spectrum of KCTD7-related disorders.
    Mastrangelo M; Sartori S; Simonati A; Brinciotti M; Moro F; Nosadini M; Pezzini F; Doccini S; Santorelli FM; Leuzzi V
    Eur J Med Genet; 2019 Dec; 62(12):103591. PubMed ID: 30500434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect.
    Metz KA; Teng X; Coppens I; Lamb HM; Wagner BE; Rosenfeld JA; Chen X; Zhang Y; Kim HJ; Meadow ME; Wang TS; Haberlandt ED; Anderson GW; Leshinsky-Silver E; Bi W; Markello TC; Pratt M; Makhseed N; Garnica A; Danylchuk NR; Burrow TA; Jayakar P; McKnight D; Agadi S; Gbedawo H; Stanley C; Alber M; Prehl I; Peariso K; Ong MT; Mordekar SR; Parker MJ; Crooks D; Agrawal PB; Berry GT; Loddenkemper T; Yang Y; Maegawa GHB; Aouacheria A; Markle JG; Wohlschlegel JA; Hartman AL; Hardwick JM
    Ann Neurol; 2018 Nov; 84(5):766-780. PubMed ID: 30295347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.